2020
Testbiotech comment on EFSA’s assessment of genetically engineered maize MON88017 for renewal authorisation under Regulation (EC) No 1829/2003 (application EFSA-GMO-RX-014) from Bayer/Monsanto (April 2020)
The EFSA GMO panel assessed genetically engineered maize MON88017 for renewal of authorisation. This maize produces• Cry3Bb1 protein against the larvae of Coleoptera (beetles) that feed below the ground;• CP4 EPSPS protein for tolerance to glyphosate-containing herbicides. Implementing Regulation 503/2013 was applied in the EFSA risk assessment.
What is (not) genetic engineering?
It is often claimed that new genetic engineering methods like CRISPR/Cas only do what continuously happens in nature anyway. Is this really true?
Overview of genome editing applications using SDN-1 and SDN-2 in regard to EU regulatory issues
New methods of genetic engineering (genome editing) and their potential impact on nature protection and the environment
Testbiotech comment on EFSA’s assessment of genetically engineered soybean SYTH0H2 for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-DE-2012-111) by Syngenta
TESTBIOTECH Background 20 - 2 -2020
Soybean SYTH0H2 contains genes conferring resistance to two groups of herbicides:• pat – for tolerance to the herbicide glufosinate• avhppd-03 – for tolerance to mesotrione and other HPPD inhibitors (such as isoxaflutole). Implementing Regulation 503/2013 was not applied in this case because the application was submitted in 2012, one year before the Implementing Regulation came weiterlesen